Provided by Chambers
Goodwin represents life sciences companies, from start-ups to large global corporations, in a wide range of transactions. The firm's strengths include joint ventures, acquisitions, licensing and collaboration agreements. The team also has experience handling financing matters for SMEs, with particular expertise in Series B fundraising.
Provided by Goodwin
Goodwin advised Emergence and its selling shareholders on its sale to Eli Lilly & Company.
Provided by Chambers
Goodwin is a very capable firm for complex M&A deals. It is a pleasure working with Goodwin's extremely deep and broad team that has significant experience.
Goodwin have years of experience of complex deal negotiations in pharmaceuticals and a deep understanding of life science-related IP matters. They constantly seek the best outcome for the client.
The Goodwin team has a deep bench of high-quality talent that offers very impressive expertise across different fields and jurisdictions.
Goodwin is a very capable firm for complex M&A deals. It is a pleasure working with Goodwin's extremely deep and broad team that has significant experience.
Goodwin have years of experience of complex deal negotiations in pharmaceuticals and a deep understanding of life science-related IP matters. They constantly seek the best outcome for the client.
The Goodwin team has a deep bench of high-quality talent that offers very impressive expertise across different fields and jurisdictions.
Provided by Chambers
Malcolm Bates negotiates licence and collaboration agreements of all kinds on behalf of life sciences companies and research institutes. He is also recommended for corporate and financing transactions.
Malcolm is a very knowledgeable lawyer.
Tim Worden regularly advises on licensing, clinical trials, distribution and R&D agreements of all kinds and associated regulatory matters. He also advises on the IP and regulatory dimensions of M&A, capital markets and venture capital transactions.
Tim has a fantastic understanding of the industry and very good attention to detail. He is strongly regarded in life sciences licensing.
Tim offers consistently good advice.
David Mardle has extensive experience advising clients in the life science and biotechnology sectors on significant M&A and financing matters.
Graham Defries' practice covers the full span of transactional matters, taking in strategic collaborations, venture capital investment and licensing deals of all kinds. His client base comprises pharmaceutical and biotech innovators as well as investors in the sector.
Graham is great to work with, both at the personal and professional level.